Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients

Iron chelation therapy (ICT) is an important tool in the treatment of transfusion-dependent lower-risk myelodysplastic syndrome (MDS) patients. ICT is effective in decreasing iron overload and consequently in limiting its detrimental effects on several organs, such as the heart, liver, and endocrine...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Sarah, Finelli, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651046/
https://www.ncbi.nlm.nih.gov/pubmed/34887690
http://dx.doi.org/10.2147/JBM.S287876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651046/
https://www.ncbi.nlm.nih.gov/pubmed/34887690
http://dx.doi.org/10.2147/JBM.S287876

Ejemplares similares